NCT04843826 (delay implant) is a NA clinical trial of papilla reconstruction in Papilla Reconstruction, sponsored by Ahmed Sadek Mohamed.

Who is sponsoring NCT04843826?

NCT04843826 is sponsored by Ahmed Sadek Mohamed.

What drugs are being tested in NCT04843826?

Interventions in NCT04843826: papilla reconstruction.

What condition does NCT04843826 study?

NCT04843826 studies Papilla Reconstruction.

Is NCT04843826 still recruiting?

NCT04843826 is currently status unknown. Last updated 14 April 2021.

Last reviewed 2021-04-14 · How we verify

NCT04843826: delay implant

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modified Pedicle Subepithelial Connective Tissue Graft for Interdental Papillary Reconstruction Around Delayed Implants in the Esthetic Zone: A Case Series Trail

Status unknown NA Last updated 14 April 2021

What this trial tests

NA trial testing papilla reconstruction in Papilla Reconstruction in 10 participants. Status unknown.

Timeline

14 April 2020

Primary endpoint
20 May 2020

14 September 2021

Quick facts

Lead sponsor	Ahmed Sadek Mohamed
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	14 April 2020
Primary completion	20 May 2020
Estimated completion	14 September 2021
Sites	1 location across Egypt

Drugs / interventions tested

papilla reconstruction

Conditions studied

Papilla Reconstruction — all drugs for Papilla Reconstruction →

Sponsor

Ahmed Sadek Mohamed

Who can join

Eligibility, any sex, with Papilla Reconstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This case series trial aims to evaluate the effect of a modified pedicle subepithelial connective tissue graft in creating anatomical papilla around one-stage delayed implant in the esthetic zone to establish better esthetics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04843826 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Sadek Mohamed
Last refreshed: 14 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04843826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing